Publications

Detailed Information

Comparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2

DC Field Value Language
dc.contributor.authorJin, Yuan-Zhe-
dc.contributor.authorZheng, Guang-Bin-
dc.contributor.authorLee, Jae Hyup-
dc.contributor.authorHan, Shi-Huan-
dc.date.accessioned2021-08-27T06:18:41Z-
dc.date.available2021-08-27T15:19:49Z-
dc.date.issued2021-08-03-
dc.identifier.citationBiomaterials Research. 2021 Aug 03;25(1):25ko_KR
dc.identifier.issn2055-7124-
dc.identifier.urihttps://hdl.handle.net/10371/174840-
dc.description.abstractBackground
Autograft has been widely used in various orthopedic and dental surgery for its superior osteogenicity, osteoinductivity and osteoconductivity. But the available volume of the autograft is limited and the efficacy of it is highly affected by the condition of the patients. Therefore, growth factors such as Escherichia coli bone morphogenetic protein-2 (ErhBMP-2) has been widely used in some countries and regions with various carriers that could affect the effects of the growth factors. Demineralized bone matrix (DBM) has been widely used as a bone graft substitute and growth factor carrier, but its effect as a carrier of ErhBMP-2 was less investigated.

Materials and methods
Rat calvaria defect model was used in this study. We implanted ErhBMP-2 with DBM or hydroxyapatite (HA) as a carrier in 8 mm calvaria defect and compared their bone regeneration effect in 4th week and 8th week after implantation with micro-CT and histology. The data was analyzed with one-way ANOVA method with Bonferroni post-hoc analysis.

Result
The group with DBM as the carrier showed significantly higher bone volume and bone thickness than the groups with HA as the carrier in both weeks. And the histology sections showed less adipose tissue formed in the groups with DBM as the carrier.

Conclusion
DBM could be a better carrier for ErhBMP-2 than HA.
ko_KR
dc.description.sponsorshipThis study was supported by a research grant for animal studies from Daewoong Pharmaceutical (Seoul, Korea) (No. 800–20140080).ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectBone morphogenetic protein-2-
dc.subjectDemineralized bone matrix-
dc.subjectHydroxyapatite-
dc.subjectCarrier-
dc.subjectBone regeneration-
dc.titleComparison of demineralized bone matrix and hydroxyapatite as carriers of Escherichia coli recombinant human BMP-2ko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이재협-
dc.identifier.doi10.1186/s40824-021-00225-7-
dc.citation.journaltitleBiomaterials Researchko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2021-08-08T03:30:37Z-
dc.citation.number1ko_KR
dc.citation.startpage25ko_KR
dc.citation.volume25ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share